Cytokinetics, Incorporated (CYTK)
NASDAQ: CYTK · Real-Time Price · USD
55.96
-0.23 (-0.41%)
Nov 13, 2024, 4:00 PM EST - Market closed

Cytokinetics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Operating Revenue
3.227.537.5970.4355.8326.87
Upgrade
Other Revenue
--87---
Upgrade
Revenue
3.227.5394.5970.4355.8326.87
Upgrade
Revenue Growth (YoY)
-58.81%-92.04%34.30%26.15%107.79%-14.71%
Upgrade
Cost of Revenue
330.76330.12240.81159.9496.9586.13
Upgrade
Gross Profit
-327.54-322.59-146.23-89.51-41.12-59.26
Upgrade
Selling, General & Admin
197.09173.61177.9896.852.8239.61
Upgrade
Operating Expenses
197.09173.61177.9896.852.8239.61
Upgrade
Operating Income
-524.63-496.21-324.2-186.31-93.94-98.87
Upgrade
Interest Expense
-80.98-57.67-51.16-29.33-38.68-27.36
Upgrade
Interest & Investment Income
44.1127.6311.340.335.334.54
Upgrade
Other Non Operating Income (Expenses)
-14.9-----
Upgrade
EBT Excluding Unusual Items
-576.4-526.24-364.02-215.31-127.29-121.69
Upgrade
Other Unusual Items
---24.94---
Upgrade
Pretax Income
-576.4-526.24-388.96-215.31-127.29-121.69
Upgrade
Net Income
-576.4-526.24-388.96-215.31-127.29-121.69
Upgrade
Net Income to Common
-576.4-526.24-388.96-215.31-127.29-121.69
Upgrade
Shares Outstanding (Basic)
1079790776558
Upgrade
Shares Outstanding (Diluted)
1079790776558
Upgrade
Shares Change (YoY)
12.36%7.46%16.83%19.16%12.07%5.80%
Upgrade
EPS (Basic)
-5.38-5.45-4.33-2.80-1.97-2.11
Upgrade
EPS (Diluted)
-5.38-5.45-4.33-2.80-1.97-2.11
Upgrade
Free Cash Flow
-407.05-415.75-310.85-191.39-2.11-93.53
Upgrade
Free Cash Flow Per Share
-3.80-4.31-3.46-2.49-0.03-1.62
Upgrade
Gross Margin
---154.59%-127.09%-73.66%-220.55%
Upgrade
Operating Margin
-16297.79%-6589.71%-342.75%-264.54%-168.27%-367.97%
Upgrade
Profit Margin
-17906.24%-6988.63%-411.21%-305.72%-228.00%-452.93%
Upgrade
Free Cash Flow Margin
-12645.23%-5521.24%-328.64%-271.76%-3.78%-348.09%
Upgrade
EBITDA
-511.14-484.31-318.39-184.04-92.11-97.57
Upgrade
EBITDA Margin
----261.31%-164.99%-
Upgrade
D&A For EBITDA
13.4811.895.812.281.831.29
Upgrade
EBIT
-524.63-496.21-324.2-186.31-93.94-98.87
Upgrade
EBIT Margin
----264.54%-168.27%-
Upgrade
Revenue as Reported
3.227.5394.5970.4355.8326.87
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.